REVOLUTION Medicines' first drug candidates exploit and improve upon the properties of amphotericin B, a powerful, broad-spectrum antifungal compound found in nature that has avoided generating significant drug resistance in 50 years of clinical use. The company is developing novel compounds that leverage the proven therapeutic mechanism for killing fungi while minimizing toxic effects on human cells.